Jon Kessler - Healthequity President CEO, Director
| 2HE Stock | EUR 98.50 0.50 0.51% |
CEO
Mr. Jon Kessler is a President, Chief Executive Officer, Director of the Company. Mr. Kessler has served as our President and Chief Executive Officer since February 2014 and as a director since March 2009. From March 2009 through January 2014, he served as our Executive Chairman. Prior to joining HealthEquity, Mr. Kessler founded WageWorks, Inc., a provider of taxadvantaged programs for consumercentric health, commuter and other employee spending account benefits, serving as Chief Executive Officer of that company from 2000 to 2004, Executive Chairman in 2005, and Chief Executive Officer from 2006 to 2007. Prior to founding WageWorks, Inc., Mr. Kessler was a benefits taxation specialist at Arthur Andersen, LLP and, prior to that, he was a senior economist in Washington, D.C., specializing in employee benefits and environmental taxation during the Clinton and Bush administrations. Mr. Kessler also currently serves as a trustee of the Employee Benefits Research Institute and a director of the International Baccalaureate Organization, both nonprofit organizations since 2014.
| Age | 55 |
| Tenure | 10 years |
| Phone | 801 727 1000 |
| Web | https://www.healthequity.com |
Jon Kessler Latest Insider Activity
Tracking and analyzing the buying and selling activities of Jon Kessler against Healthequity stock is an integral part of due diligence when investing in Healthequity. Jon Kessler insider activity provides valuable insight into whether Healthequity is net buyers or sellers over its current business cycle. Note, Healthequity insiders must abide by specific rules, including filing SEC forms every time they buy or sell Healthequity'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Jon Kessler over two months ago Disposition of 1511 shares by Jon Kessler of HealthEquity at 78.9334 subject to Rule 16b-3 | ||
Jon Kessler over three months ago Disposition of 2781 shares by Jon Kessler of HealthEquity at 83.0782 subject to Rule 16b-3 | ||
Jon Kessler over three months ago Disposition of 2199 shares by Jon Kessler of HealthEquity at 83.6511 subject to Rule 16b-3 | ||
Jon Kessler over six months ago Disposition of 6279 shares by Jon Kessler of HealthEquity at 74.2552 subject to Rule 16b-3 |
Healthequity Management Efficiency
Healthequity's management efficiency ratios could be used to measure how well Healthequity manages its routine affairs as well as how well it operates its assets and liabilities.Management Performance
| Return On Equity | -0.0313 | |||
| Return On Asset | 0.0037 |
Healthequity Leadership Team
Elected by the shareholders, the Healthequity's board of directors comprises two types of representatives: Healthequity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Healthequity. The board's role is to monitor Healthequity's management team and ensure that shareholders' interests are well served. Healthequity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Healthequity's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jon Kessler, President CEO, Director | ||
| Darcy Mott, CFO, Executive Vice President | ||
| Delano Ladd, Executive Vice President General Counsel and Corporate Secretary | ||
| Brad Bennion, Sr Devel | ||
| Tyson Murdock, Ex CFO | ||
| Elimelech Rosner, Ex CTO | ||
| Tia Padia, VP Marketing | ||
| Richard Putnam, IR Contact Officer | ||
| Steve Lindsay, Ex Management | ||
| Larry Trittschuh, Executive Vice President Chief Security Officer |
Healthequity Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Healthequity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0313 | |||
| Return On Asset | 0.0037 | |||
| Profit Margin | (0.07) % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 5.61 B | |||
| Shares Outstanding | 84.64 M | |||
| Shares Owned By Insiders | 1.96 % | |||
| Shares Owned By Institutions | 98.04 % | |||
| Price To Earning | 48.79 X | |||
| Price To Book | 2.82 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Healthequity Stock
When determining whether Healthequity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Healthequity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Healthequity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Healthequity Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Healthequity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Healthequity Stock please use our How to Invest in Healthequity guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.